Adaptive Bio Ownership 2024 | Who Owns Adaptive Bio Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

100.71%

Insider Ownership

1.93%

Retail Ownership

-2.64%

Institutional Holders

164.00

Adaptive Bio Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VIKING GLOBAL INVESTORS LP20.57%0.42%29,993,708--108,577,223Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP9.60%1.33%14,000,0003,500,00033.33%50,680,000Jun 30, 2024
BLACKROCK INC.8.00%0.00%11,664,002473,8834.23%42,223,686Jun 30, 2024
MATRIX CAPITAL MANAGEMENT COMPANY, LP7.94%0.32%11,572,590--41,892,776Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC7.83%0.37%11,412,000850,7048.05%41,311,440Jun 30, 2024
VANGUARD GROUP INC7.01%0.00%10,226,911-2,642,907-20.54%37,021,417Jun 30, 2024
MILLENNIUM MANAGEMENT LLC6.35%0.02%9,262,3418,426,5801008.25%33,529,674Jun 30, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.4.75%0.29%6,919,778743,07112.03%24,980,399Jun 30, 2024
SUMITOMO MITSUI TRUST HOLDINGS, INC.4.73%0.02%6,899,631722,92411.70%24,976,664Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2.68%0.00%3,912,0271,319,70950.91%14,161,538Jun 30, 2024
ARISTOTLE ATLANTIC PARTNERS, LLC2.04%0.35%2,974,188-18,375-0.61%10,766,561Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.84%0.00%2,682,328103,2024.00%9,712,356Jun 30, 2024
STATE STREET CORP1.72%0.00%2,502,900-177,646-6.63%9,060,498,000Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.1.18%0.55%1,720,0001,720,000100.00%6,226,400Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA1.15%0.01%1,682,005-1,818,959-51.96%6,088,858Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.94%0.00%1,369,097-374,519-21.48%4,955,077Jun 30, 2024
BANK OF AMERICA CORP /DE/0.78%0.00%1,141,204623,932120.62%4,131,158Jun 30, 2024
PIER CAPITAL, LLC0.72%0.57%1,055,299-48,142-4.36%3,820,182Jun 30, 2024
GOLDMAN SACHS GROUP INC0.72%0.00%1,048,012421,29167.22%3,793,803Jun 30, 2024
ABRDN PLC0.71%0.01%1,029,447--3,726,598Jun 30, 2024

Adaptive Bio's largest institutional shareholder is VIKING GLOBAL INVESTORS LP, holding 20.57% of the company's total share outstanding, currently valued at $108.58M. The top 10 institutional shareholders own together 79.47% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RUBRIC CAPITAL MANAGEMENT LP9.60%1.33%14,000,0003,500,00033.33%50,680,000Jun 30, 2024
TEJARA CAPITAL LTD0.62%1.20%909,061640,047237.92%3,290,801Jun 30, 2024
PIER CAPITAL, LLC0.72%0.57%1,055,299-48,142-4.36%3,820,182Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.1.18%0.55%1,720,0001,720,000100.00%6,226,400Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC0.43%0.42%623,825346,729125.13%2,258,247Jun 30, 2024
VIKING GLOBAL INVESTORS LP20.57%0.42%29,993,708--108,577,223Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC7.83%0.37%11,412,000850,7048.05%41,311,440Jun 30, 2024
ARISTOTLE ATLANTIC PARTNERS, LLC2.04%0.35%2,974,188-18,375-0.61%10,766,561Jun 30, 2024
DDD PARTNERS, LLC0.53%0.32%769,99730,2584.09%2,787,389Jun 30, 2024
MATRIX CAPITAL MANAGEMENT COMPANY, LP7.94%0.32%11,572,590--41,892,776Jun 30, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.4.75%0.29%6,919,778743,07112.03%24,980,399Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC0.14%0.10%209,70281,64863.76%759,121Jun 30, 2024
LEEWARD FINANCIAL PARTNERS, LLC0.04%0.08%51,650--186,973Jun 30, 2024
PDT PARTNERS, LLC0.15%0.07%215,004--778,314Jun 30, 2024
RAPPAPORT REICHES CAPITAL MANAGEMENT, LLC0.05%0.07%68,080--246,450Jun 30, 2024
EDGE WEALTH MANAGEMENT LLC0.06%0.07%90,000--325,800Jun 30, 2024
BOUVEL INVESTMENT PARTNERS, LLC0.03%0.06%45,880-150-0.33%166,084Jun 30, 2024
CRAWFORD FUND MANAGEMENT, LLC0.03%0.04%40,500-71,500-63.84%146,610Jun 30, 2024
ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC0.13%0.03%183,786--665,305Jun 30, 2024
AVENIR CORP0.05%0.03%76,36510,00015.07%276,441Jun 30, 2024

The largest Adaptive Bio shareholder by % of total assets is RUBRIC CAPITAL MANAGEMENT LP. The company owns 14.00M shares of Adaptive Bio (ADPT), representing 1.33% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC6.35%0.02%9,262,3418,426,5801008.25%33,529,674Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP9.60%1.33%14,000,0003,500,00033.33%50,680,000Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.1.18%0.55%1,720,0001,720,000100.00%6,226,400Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2.68%0.00%3,912,0271,319,70950.91%14,161,538Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC7.83%0.37%11,412,000850,7048.05%41,311,440Jun 30, 2024
NIKKO ASSET MANAGEMENT AMERICAS, INC.4.75%0.29%6,919,778743,07112.03%24,980,399Jun 30, 2024
SUMITOMO MITSUI TRUST HOLDINGS, INC.4.73%0.02%6,899,631722,92411.70%24,976,664Jun 30, 2024
JPMORGAN CHASE & CO0.62%0.00%902,557689,050322.73%3,267,255Jun 30, 2024
TEJARA CAPITAL LTD0.62%1.20%909,061640,047237.92%3,290,801Jun 30, 2024
BANK OF AMERICA CORP /DE/0.78%0.00%1,141,204623,932120.62%4,131,158Jun 30, 2024
BLACKROCK INC.8.00%0.00%11,664,002473,8834.23%42,223,686Jun 30, 2024
TUDOR INVESTMENT CORP ET AL0.35%0.01%515,384452,252716.36%1,865,690Jun 30, 2024
GOLDMAN SACHS GROUP INC0.72%0.00%1,048,012421,29167.22%3,793,803Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC0.43%0.42%623,825346,729125.13%2,258,247Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.12%0.00%182,076129,201244.35%635,445Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.84%0.00%2,682,328103,2024.00%9,712,356Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.10%0.00%151,80099,217188.69%549,516Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC0.14%0.10%209,70281,64863.76%759,121Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.05%0.01%67,25267,252100.00%243,452Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.32%0.00%460,13264,78816.39%1,665,677Jun 30, 2024

As of Jun 30 2024, Adaptive Bio's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 8.43M stocks of ADPT, valued at $33.53M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC7.01%0.00%10,226,911-2,642,907-20.54%37,021,417Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA1.15%0.01%1,682,005-1,818,959-51.96%6,088,858Jun 30, 2024
BLUE WATER LIFE SCIENCE ADVISORS, LP----1,687,665-100.00%-Jun 30, 2024
BRAIDWELL LP----1,357,490-100.00%-Jun 30, 2024
GILDER GAGNON HOWE & CO LLC----1,245,111-100.00%-Jun 30, 2024
FEDERATED HERMES, INC.0.04%0.00%57,272-1,244,445-95.60%207,325,000Jun 30, 2024
NORDEA INVESTMENT MANAGEMENT AB----859,214-100.00%-Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.----844,852-100.00%-Jun 30, 2024
AMERIPRISE FINANCIAL INC0.03%-50,909-795,470-93.99%184,290Jun 30, 2024
NEWTYN MANAGEMENT, LLC----623,690-100.00%-Jun 30, 2024
PEREGRINE CAPITAL MANAGEMENT LLC----375,716-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.94%0.00%1,369,097-374,519-21.48%4,955,077Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----274,700-100.00%-Jun 30, 2024
CERITY PARTNERS LLC0.30%0.00%437,484-238,760-35.31%1,583,694Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----203,941-100.00%-Jun 30, 2024
SWISS NATIONAL BANK----199,600-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC0.24%0.00%354,842-198,919-35.92%1,284,528Jun 30, 2024
STATE STREET CORP1.72%0.00%2,502,900-177,646-6.63%9,060,498,000Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----175,821-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----162,137-100.00%-Jun 30, 2024

As of Jun 30 2024, Adaptive Bio's biggest institutional seller is VANGUARD GROUP INC. The company sold -2.64M shares of ADPT, valued at $37.02M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SOLEUS CAPITAL MANAGEMENT, L.P.1.18%0.55%1,720,0001,720,000100.00%6,226,400Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.05%0.01%67,25267,252100.00%243,452Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.04%0.00%62,31162,311100.00%225,566Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.00%56,94556,945100.00%206,141Jun 30, 2024
CANADA PENSION PLAN INVESTMENT BOARD0.02%0.00%27,20027,200100.00%98,464Jun 30, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC0.02%0.00%22,32522,325100.00%80,817Jun 30, 2024
IQ EQ FUND MANAGEMENT (IRELAND) LTD0.01%0.01%19,75019,750100.00%71,495Jun 30, 2024
IMPACT PARTNERSHIP WEALTH, LLC0.01%0.02%17,15417,154100.00%62,097Jun 30, 2024
BANK OF MONTREAL /CAN/0.01%-13,30313,303100.00%48,157Jun 30, 2024
VONTOBEL HOLDING LTD.0.01%0.00%13,00013,000100.00%47,060Jun 30, 2024
PRUDENTIAL FINANCIAL INC0.01%0.00%11,66511,665100.00%42,227Jun 30, 2024
DLK INVESTMENT MANAGEMENT, LLC0.01%0.02%10,10010,100100.00%36,562Jun 30, 2024
MUTUAL ADVISORS, LLC0.01%0.00%10,04010,040100.00%44,578Jun 30, 2024
OPTIVER HOLDING B.V.0.00%-1,8051,805100.00%6,534Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.00%0.00%1,7101,710100.00%6,190Jun 30, 2024
ARCHER INVESTMENT CORP0.00%0.00%1,0001,000100.00%3,620Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%572572100.00%1,979Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%-9797100.00%352Jun 30, 2024
MATHER GROUP, LLC.--3030100.00%96Jun 30, 2024

Adaptive Bio's largest new institutional shareholder by number of shares is SOLEUS CAPITAL MANAGEMENT, L.P., purchased 1.72M shares, valued at $6.23M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLUE WATER LIFE SCIENCE ADVISORS, LP----1,687,665-100.00%-Jun 30, 2024
BRAIDWELL LP----1,357,490-100.00%-Jun 30, 2024
GILDER GAGNON HOWE & CO LLC----1,245,111-100.00%-Jun 30, 2024
NORDEA INVESTMENT MANAGEMENT AB----859,214-100.00%-Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.----844,852-100.00%-Jun 30, 2024
NEWTYN MANAGEMENT, LLC----623,690-100.00%-Jun 30, 2024
PEREGRINE CAPITAL MANAGEMENT LLC----375,716-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----274,700-100.00%-Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----203,941-100.00%-Jun 30, 2024
SWISS NATIONAL BANK----199,600-100.00%-Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----175,821-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----162,137-100.00%-Jun 30, 2024
MACQUARIE GROUP LTD----121,185-100.00%-Jun 30, 2024
TRIATOMIC MANAGEMENT LP----98,555-100.00%-Jun 30, 2024
CENTIVA CAPITAL, LP----60,465-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----55,983-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----50,502-100.00%-Jun 30, 2024
VERSOR INVESTMENTS LP----45,200-100.00%-Jun 30, 2024
AMUNDI----43,930-100.00%-Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC----43,859-100.00%-Jun 30, 2024
JANUS HENDERSON GROUP PLC----42,686-100.00%-Jun 30, 2024
ARIZONA STATE RETIREMENT SYSTEM----27,851-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----26,474-100.00%-Jun 30, 2024
PIER 88 INVESTMENT PARTNERS LLC----26,415-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----24,986-100.00%-Jun 30, 2024
ZURCHER KANTONALBANK (ZURICH CANTONALBANK)----21,364-100.00%-Jun 30, 2024
XTX TOPCO LTD----17,036-100.00%-Jun 30, 2024
GREAT WEST LIFE ASSURANCE CO /CAN/----12,950-100.00%-Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC----12,120-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----11,731-100.00%-Jun 30, 2024
MELFA WEALTH MANAGEMENT, LLC----10,100-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----3,808-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----3,462-100.00%-Jun 30, 2024
BANQUE CANTONALE VAUDOISE----300-100.00%-Jun 30, 2024
AVION WEALTH----139-100.00%-Jun 30, 2024
ASSETMARK, INC----80-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----24-100.00%-Jun 30, 2024

Adaptive Bio's largest sold out institutional shareholder by shares sold is BLUE WATER LIFE SCIENCE ADVISORS, LP, sold -1.69M shares, valued at -, as of undefined.

Adaptive Bio Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SPARROW FUNDS3.49%12,425--Feb 29, 2024
SPARROW FUNDS3.24%11,545--Feb 29, 2024
T. Rowe Price New Horizons Fund, Inc.1.58%7,882,478--Mar 31, 2024
Ark ETF Trust1.35%10,871,678-408,573-3.62%Jan 31, 2024
MASTER FOCUS GROWTH LLC1.00%349,867--Nov 30, 2020
TEKLA LIFE SCIENCES INVESTORS0.81%381,660105,74838.33%Mar 31, 2024
TEKLA HEALTHCARE INVESTORS0.76%647,78758,4969.93%Mar 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.64%590,058--Jan 31, 2024
MFS SERIES TRUST IV0.37%1,283,909--Feb 29, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.27%167,86730,70422.39%Feb 29, 2024
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.20%68,154--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.18%95,724--Mar 31, 2024
Collaborative Investment Series Trust0.18%27,973--Mar 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.14%438,778--Mar 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.13%481,898--Mar 31, 2024
PFM Multi-Manager Series Trust0.12%102,2692,4782.48%Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.0.11%363,947--Mar 31, 2024
BlackRock Innovation & Growth Trust0.11%115,349--Mar 31, 2024
NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST0.11%200,000--Mar 31, 2024
Humankind Benefit Corp0.11%2,36072744.52%Dec 31, 2023
MARSICO INVESTMENT FUND0.09%106,723--Mar 31, 2024
Federated Hermes MDT Series0.07%182,028--Jan 31, 2024
MFS SERIES TRUST I0.07%1,431,544--Feb 29, 2024
SARATOGA ADVANTAGE TRUST0.07%4,289--Feb 29, 2024
REYNOLDS FUNDS INC0.06%700--Mar 31, 2024
NEUBERGER BERMAN EQUITY FUNDS0.06%600,000--Feb 29, 2024
RENAISSANCE CAPITAL GREENWICH FUNDS0.06%44,363--Mar 31, 2024
ALLSPRING VARIABLE TRUST0.05%30,231--Mar 31, 2024
T. Rowe Price Tax-Efficient Funds, Inc.0.05%4,527--Feb 29, 2024
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0.04%300,000--Mar 31, 2024
VANGUARD EXPLORER FUND0.04%484,990130,20036.70%Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.04%6,969--Mar 28, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.03%128,228--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.03%198,418-12,399-5.88%Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%17,467--Mar 31, 2024
BUFFALO FUNDS0.03%192,695--Mar 31, 2024
ALGER FUNDS0.03%26,105--Jan 31, 2024
VANGUARD INDEX FUNDS0.03%10,992,318-1,587,798-12.62%Mar 31, 2024
ALGER PORTFOLIOS0.03%9,718--Dec 31, 2023
Calvert Responsible Index Series, Inc.0.03%41,573--Mar 31, 2024
T. Rowe Price Equity Funds, Inc.0.02%260,406--Mar 31, 2024
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.02%723,891--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%71,8401,7882.55%Feb 29, 2024
GROWTH FUND OF AMERICA0.02%539,605--Feb 29, 2024
Federated Hermes Adviser Series0.02%126,80112,84611.27%Mar 31, 2024
SMALLCAP WORLD FUND INC0.02%1,407,980--Mar 31, 2024
FIDELITY CONTRAFUND0.02%1,232,959--Mar 31, 2024
Horizon Funds0.02%30,435--Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.01%3,224--Mar 31, 2024
ALGER INSTITUTIONAL FUNDS0.01%3,688--Jan 31, 2024
DEUTSCHE DWS INVESTMENT TRUST0.01%43,198--Jan 31, 2024
MFS VARIABLE INSURANCE TRUST0.01%421,9762,3620.56%Mar 31, 2024
PRIMECAP Odyssey Funds0.01%104,230--Jan 31, 2024
Fidelity Commonwealth Trust II0.01%71,283--Aug 31, 2023
SEI Catholic Values Trust0.01%26,413--Feb 29, 2024
MASTER LARGE CAP SERIES LLC0.01%7,983--Mar 31, 2022
VIRTUS ASSET TRUST0.01%199,200--Mar 28, 2024
SCHWAB CAPITAL TRUST0.01%308,382-2,746-0.88%Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.01%163,408--Feb 29, 2024
MFS VARIABLE INSURANCE TRUST III0.01%86,920-3,533-3.91%Mar 31, 2024
BlackRock ETF Trust0.01%4,578--Jan 31, 2024
ETF Managers Trust0.00%36,706-5,443-12.91%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%988,725-71,806-6.77%Feb 29, 2024
Ultimus Managers Trust0.00%51,869--Feb 29, 2024
UBS FUNDS0.00%20,561--Mar 31, 2024
Calvert Variable Products, Inc.0.00%11,286--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%50,7835351.06%Mar 31, 2024
John Hancock Exchange-Traded Fund Trust0.00%25,127--Jan 31, 2024
WASATCH FUNDS TRUST0.00%34,208--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%80,94628,19553.45%Mar 31, 2024
Forethought Variable Insurance Trust0.00%13,387--Mar 28, 2024
FIDELITY COVINGTON TRUST0.00%56,331-652-1.14%Mar 31, 2024
OPTIMUM FUND TRUST0.00%121,185-2,113-1.71%Mar 28, 2024
ALLSPRING MASTER TRUST0.00%179,264-805-0.45%Feb 29, 2024
MFS SERIES TRUST V0.00%154,226--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%77,298-6,306-7.54%Mar 31, 2024
MASTER ADVANTAGE SMID CAP LLC0.00%308--Dec 31, 2020
Segall Bryant & Hamill Trust0.00%43,788--Mar 31, 2024
AMG FUNDS0.00%67,000--Mar 28, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%9,2853,78068.66%Mar 31, 2024
MASSMUTUAL PREMIER FUNDS0.00%58,113--Dec 31, 2023
BARON SELECT FUNDS0.00%17,833--Mar 31, 2024
NUVEEN INVESTMENT FUNDS INC0.00%57,302--Jan 31, 2024
AMG FUNDS III0.00%8,421--Mar 28, 2024
AMG Funds I0.00%3,180--Jan 31, 2024
VANGUARD WORLD FUND0.00%382,65315,6934.28%Feb 29, 2024
T. Rowe Price Spectrum Funds II, Inc.0.00%21,957--Feb 29, 2024
North Square Investments Trust0.00%14,760--Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%79,08279,082-Mar 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%49,19610,34626.63%Mar 31, 2024
FIDELITY SECURITIES FUND0.00%138,900--Jan 31, 2024
Principal Exchange-Traded Funds0.00%18,281-1,502-7.59%Mar 31, 2024
Dimensional ETF Trust0.00%599,156224,55959.95%Jan 31, 2024
Amplify ETF Trust0.00%37,25637,256-Mar 31, 2024
VANGUARD HORIZON FUNDS0.00%28,100--Mar 31, 2024
MORGAN STANLEY INSTITUTIONAL FUND INC0.00%81,974--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%37,719-8,093-17.67%Mar 31, 2024
Meeder Funds0.00%5,632--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%5,651--Mar 31, 2024
OHIO NATIONAL FUND INC0.00%22,888--Mar 31, 2024

Adaptive Bio's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 12.43K shares, compromising 3.49% of its total assets.

Adaptive Bio Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24164-14.14%
31 Mar, 24191-4.50%
31 Dec, 232005.26%
30 Sep, 23190-10.38%
30 Jun, 23212-7.42%
31 Mar, 232290.88%
31 Dec, 222273.65%
30 Sep, 222194.29%
30 Jun, 22210-6.67%
31 Mar, 222254.17%
31 Dec, 21216-2.70%
30 Sep, 21222-5.93%
30 Jun, 21236-7.45%
31 Mar, 21255-1.54%
31 Dec, 2025919.91%
30 Sep, 202165.37%
30 Jun, 2020535.76%
31 Mar, 2015111.03%
31 Dec, 1913610.57%
30 Sep, 1912310.81%
30 Jun, 1911111000.00%
31 Mar, 191-
30 Sep, 161-

As of 30 Jun 24, 164 institutions are holding Adaptive Bio's shares, representing a decrease of -14.14% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24146,826,5793.08%
31 Mar, 24142,434,185-0.71%
31 Dec, 23143,448,1982.15%
30 Sep, 23140,422,1542.47%
30 Jun, 23137,039,9562.52%
31 Mar, 23133,674,6200.71%
31 Dec, 22132,735,5421.42%
30 Sep, 22130,877,429-2.55%
30 Jun, 22134,305,0626.94%
31 Mar, 22125,588,2761.80%
31 Dec, 21123,370,0514.76%
30 Sep, 21117,763,4980.34%
30 Jun, 21117,359,5303.21%
31 Mar, 21113,712,197-0.32%
31 Dec, 20114,074,9312.49%
30 Sep, 20111,304,95910.24%
30 Jun, 20100,963,5074.25%
31 Mar, 2096,850,36412.21%
31 Dec, 1986,314,2886.37%
30 Sep, 1981,145,2013.73%
30 Jun, 1978,228,11975162.04%
31 Mar, 19103,941-
30 Sep, 16235-

Adaptive Bio (ADPT) has 146.83M shares outstanding as of 30 Jun 24, up 3.08% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 24100.71%1.06%
31 Mar, 2497.70%0.99%
31 Dec, 2399.35%1.06%
30 Sep, 2397.04%1.08%
30 Jun, 2394.90%1.09%
31 Mar, 2393.15%1.08%
31 Dec, 2292.79%1.11%
30 Sep, 2291.57%1.00%
30 Jun, 2295.48%1.22%
31 Mar, 2288.63%1.14%
31 Dec, 2187.99%1.26%
30 Sep, 2183.62%1.20%
30 Jun, 2183.61%1.25%
31 Mar, 2181.83%1.18%
31 Dec, 2083.29%1.21%
30 Sep, 2082.83%1.32%
30 Jun, 2079.26%1.34%
31 Mar, 2076.83%0.49%
31 Dec, 19124.79%0.91%
30 Sep, 19117.32%0.92%
30 Jun, 19113.10%500745.44%
31 Mar, 190.15%-
30 Sep, 160.00%-

As of 30 Jun 24, Adaptive Bio is held by 100.71% institutional shareholders, representing a 1.06% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2485-1.16%
31 Mar, 2486-11.34%
31 Dec, 239727.63%
30 Sep, 2376-5.00%
30 Jun, 2380-28.57%
31 Mar, 23112-4.27%
31 Dec, 22117-
30 Sep, 22117-0.85%
30 Jun, 22118-13.24%
31 Mar, 2213633.33%
31 Dec, 21102-0.97%
30 Sep, 21103-23.13%
30 Jun, 21134-5.63%
31 Mar, 21142-1.39%
31 Dec, 201445.88%
30 Sep, 2013610.57%
30 Jun, 2012311.82%
31 Mar, 2011030.95%
31 Dec, 19842.44%
30 Sep, 1982-25.45%
30 Jun, 1911010900.00%
31 Mar, 191-
30 Sep, 161-

85 institutional shareholders have increased their position in ADPT stock as of 30 Jun 24 compared to 86 in the previous quarter (a -1.16% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2443-34.85%
31 Mar, 2466-7.04%
31 Dec, 2371-2.74%
30 Sep, 2373-7.59%
30 Jun, 237925.40%
31 Mar, 2363-5.97%
31 Dec, 226711.67%
30 Sep, 22607.14%
30 Jun, 225616.67%
31 Mar, 2248-30.43%
31 Dec, 21699.52%
30 Sep, 21633.28%
30 Jun, 2161-21.79%
31 Mar, 2178-
31 Dec, 207877.27%
30 Sep, 2044-12.00%
30 Jun, 2050108.33%
31 Mar, 2024-20.00%
31 Dec, 193020.00%
30 Sep, 1925-
30 Jun, 19--
31 Mar, 19--
30 Sep, 16--

43 institutional shareholders have reduced their position in ADPT stock as of 30 Jun 24 compared to 66 in the previous quarter (a -34.85% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24164-14.14%146,826,5793.08%100.71%1.06%85-1.16%43-34.85%
31 Mar, 24191-4.50%142,434,185-0.71%97.70%0.99%86-11.34%66-7.04%
31 Dec, 232005.26%143,448,1982.15%99.35%1.06%9727.63%71-2.74%
30 Sep, 23190-10.38%140,422,1542.47%97.04%1.08%76-5.00%73-7.59%
30 Jun, 23212-7.42%137,039,9562.52%94.90%1.09%80-28.57%7925.40%
31 Mar, 232290.88%133,674,6200.71%93.15%1.08%112-4.27%63-5.97%
31 Dec, 222273.65%132,735,5421.42%92.79%1.11%117-6711.67%
30 Sep, 222194.29%130,877,429-2.55%91.57%1.00%117-0.85%607.14%
30 Jun, 22210-6.67%134,305,0626.94%95.48%1.22%118-13.24%5616.67%
31 Mar, 222254.17%125,588,2761.80%88.63%1.14%13633.33%48-30.43%
31 Dec, 21216-2.70%123,370,0514.76%87.99%1.26%102-0.97%699.52%
30 Sep, 21222-5.93%117,763,4980.34%83.62%1.20%103-23.13%633.28%
30 Jun, 21236-7.45%117,359,5303.21%83.61%1.25%134-5.63%61-21.79%
31 Mar, 21255-1.54%113,712,197-0.32%81.83%1.18%142-1.39%78-
31 Dec, 2025919.91%114,074,9312.49%83.29%1.21%1445.88%7877.27%
30 Sep, 202165.37%111,304,95910.24%82.83%1.32%13610.57%44-12.00%
30 Jun, 2020535.76%100,963,5074.25%79.26%1.34%12311.82%50108.33%
31 Mar, 2015111.03%96,850,36412.21%76.83%0.49%11030.95%24-20.00%
31 Dec, 1913610.57%86,314,2886.37%124.79%0.91%842.44%3020.00%
30 Sep, 1912310.81%81,145,2013.73%117.32%0.92%82-25.45%25-
30 Jun, 1911111000.00%78,228,11975162.04%113.10%500745.44%11010900.00%--
31 Mar, 191-103,941-0.15%-1---
30 Sep, 161-235-0.00%-1---

Adaptive Bio Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 06, 2024PISKEL KYLEofficer Principal Accounting OfficerS-SaleSell7,727$3.43$26.50K123,318
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselS-SaleSell6,772$3.43$23.23K172,896
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselS-SaleSell6,609$3.44$22.73K166,287

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 13, 2024NEUPERT PETER Mdirector-M-ExemptSell15,000$0.84$12.60K-
Mar 06, 2024PISKEL KYLEofficer Principal Accounting OfficerS-SaleSell7,727$3.43$26.50K123,318
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselS-SaleSell6,772$3.43$23.23K172,896
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselS-SaleSell6,609$3.44$22.73K166,287

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024PISKEL KYLEofficer Chief Financial OfficerA-AwardBuy31,260--154,578
Mar 13, 2024NEUPERT PETER Mdirector-M-ExemptBuy15,000$0.84$12.60K169,296
Mar 13, 2024NEUPERT PETER Mdirector-M-ExemptSell15,000$0.84$12.60K-
Mar 06, 2024Pellini Michael Jdirector-A-AwardBuy31,328--54,296
Mar 06, 2024Pellini Michael Jdirector-A-AwardBuy48,044$3.99$191.70K48,044
Mar 06, 2024OWEN KATEY EINTERZdirector-A-AwardBuy31,328--57,235
Mar 06, 2024OWEN KATEY EINTERZdirector-A-AwardBuy48,044$3.99$191.70K48,044
Mar 06, 2024NEUPERT PETER Mdirector-A-AwardBuy31,328--154,296
Mar 06, 2024NEUPERT PETER Mdirector-A-AwardBuy48,044$3.99$191.70K48,044
Mar 06, 2024HERSHBERG ROBERTdirector-A-AwardBuy31,328--107,296
Mar 06, 2024HERSHBERG ROBERTdirector-A-AwardBuy48,044$3.99$191.70K48,044
Mar 06, 2024GRIFFIN MICHELLE RENEEdirector-A-AwardBuy31,328--51,955
Mar 06, 2024GRIFFIN MICHELLE RENEEdirector-A-AwardBuy48,044$3.99$191.70K48,044
Mar 06, 2024PISKEL KYLEofficer Principal Accounting OfficerA-AwardBuy43,740--131,045
Mar 06, 2024PISKEL KYLEofficer Principal Accounting OfficerS-SaleSell7,727$3.43$26.50K123,318
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselA-AwardBuy39,990--179,668
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselS-SaleSell6,772$3.43$23.23K172,896
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselS-SaleSell6,609$3.44$22.73K166,287
Mar 06, 2024Taylor Stacy Lofficer SVP and General CounselA-AwardBuy60,010$3.99$239.44K60,010
Mar 06, 2024LO FRANCISofficer Chief People OfficerA-AwardBuy99,976--268,445

The last insider sell of Adaptive Bio's stock was made by NEUPERT PETER M on Mar 13 2024, selling 15,000 shares at $0.84 per share (valued at $12.60K).

Adaptive Bio Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241--
Q1 20242424100.00%
Q4 20231250.00%
Q3 2023-2-
Q2 20232825.00%
Q1 20233215213.33%
Q4 2022-5-
Q1 20221414100.00%
Q4 20212366.67%
Q3 202141428.57%
Q2 2021194641.30%
Q1 20216823229.31%
Q4 20203111526.96%
Q3 2020226732.84%
Q2 2020245543.64%
Q1 2020223759.46%
Q4 2019112250.00%
Q3 20191514107.14%
Q2 2019-32-
Q2 20171250.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Adaptive Bio's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024-14-
Q4 2023-1-
Q3 2023-2-
Q2 2023-6-
Q1 2023-14-
Q4 2022-5-
Q1 2022-10-
Q4 2021-1-
Q3 2021-10-
Q2 2021-27-
Q1 2021-175-
Q4 2020-78-
Q3 2020-39-
Q2 2020-30-
Q1 2020-18-
Q4 2019-10-
Q3 20191--
Q2 2019---
Q2 2017---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Adaptive Bio's stocks.

Adaptive Bio Peer Ownership


TickerCompany
SANASana Biotechnology, Inc.
CWBRCohBar, Inc.
VECTVectivBio Holding AG
IKNAIkena Oncology, Inc.
APLSApellis Pharmaceuticals, Inc.
RPHMReneo Pharmaceuticals, Inc.
VERVVerve Therapeutics, Inc.
LEGNLegend Biotech Corporation
KNTEKinnate Biopharma Inc.
AVROAVROBIO, Inc.
CRBUCaribou Biosciences, Inc.
VIRVir Biotechnology, Inc.
KRYSKrystal Biotech, Inc.
RPRXRoyalty Pharma plc
BEAMBeam Therapeutics Inc.
HEPAHepion Pharmaceuticals, Inc.
ZURAZura Bio Limited
ELEVElevation Oncology, Inc.
ENVBEnveric Biosciences, Inc.

ADPT Ownership FAQ


Adaptive Bio is owned by institutional shareholders (100.71%), insiders (1.93%), and public (-2.64%). The largest institutional shareholder of Adaptive Bio is VIKING GLOBAL INVESTORS LP (20.57% of total shares) and the top mutual fund owner is SPARROW FUNDS (3.49% of total shares).

Adaptive Bio's major institutional shareholders are VIKING GLOBAL INVESTORS LP, RUBRIC CAPITAL MANAGEMENT LP, BLACKROCK INC., MATRIX CAPITAL MANAGEMENT COMPANY, LP, and ARK INVESTMENT MANAGEMENT LLC. The top five shareholders own together 53.94% of the company's share outstanding.

As of Jun 2024, there are 164 institutional shareholders of Adaptive Bio.

VIKING GLOBAL INVESTORS LP owns 29.99M shares of Adaptive Bio, representing 20.57% of the company's total shares outstanding, valued at $108.58M (as of Jun 2024).

As of Jun 2024, RUBRIC CAPITAL MANAGEMENT LP holds 14M shares of Adaptive Bio (ADPT), compromising 9.60% of the company, valued at $50.68M.

BLACKROCK INC is the third largest holder of Adaptive Bio. The company owns 11.66M of the company's shares outstanding (worth $42.22M).